abstract |
The present invention relates to novel disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds represented by the following general formula (I), pharmaceutical compositions containing these compounds, and chemokine-mediated It relates to the use of these compounds and their compositions for treating lesions. |